Prudential Financial »

Rapport Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.7M 255k 30.34

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Equity Marke (DFUS)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Prudential Financial

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics